FORT LEE, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global specialty pharmaceutical company, announced today that Alpharma’s senior management will provide an overview of the company’s business at the UBS Global Life Sciences Conference on Tuesday, September 26, 2006 at 3:30 P.M. at The Grand Hyatt Hotel in New York City.
An audio transmission of the presentation will be available live and by replay. The replay of the presentation will begin 3 hours after the actual presentation time and will be available until October 8, 2006. To access the audio webcast go to http://www.ibb.ubs.com, and click on “Conferences” box.
Alpharma press releases are also available at our website: http://www.alpharma.com.
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma Inc.
CONTACT: Kathleen Makrakis - VP, Investor Relations, +1-201-228-5085,kathleen.makrakis@alpharma.com
Web site: http://www.alpharma.com/
